Press Releases
- QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients
- QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients
- QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients
- Simulations Plus to Acquire Cognigen Corporation
- PHT Corporation Reports Record Breaking 2nd Quarter as Pharma Industry Champions Patient-Driven eData Systems in Clinical Research
- More Press Releases
Featured Jobs

